Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

Beck Marco; Munk Marion R.; Ebneter Andreas; Wolf Sebastian; Zinkernagel Martin S.

首页> 外文期刊>American Journal of Ophthalmology: The International Journal of Ophthalmology >Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

【24h】

Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

机译：抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的患者视网膜神经节细胞层变化

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

PURPOSE: To evaluate macular retinal ganglion cell thickness in patients with neovascular age-related macular degeneration (AMD) and intravitreal anti vascular endothelial growth factor (VEGF) therapy.

机译：目的：评估新血管性年龄相关性黄斑变性（AMD）和玻璃体内抗血管内皮生长因子（VEGF）治疗患者的黄斑视网膜神经节细胞厚度。

著录项

来源
《American Journal of Ophthalmology: The International Journal of Ophthalmology 》 |2016年第null期| 共8页
作者
Beck Marco; Munk Marion R.; Ebneter Andreas; Wolf Sebastian; Zinkernagel Martin S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration [J] . Beck Marco, Munk Marion R., Ebneter Andreas, American Journal of Ophthalmology: The International Journal of Ophthalmology . 2016 ,第Null期

机译：抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的患者视网膜神经节细胞层变化
2. Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761) Reply [J] . Maguire Maureen G. Ophthalmology . 2017 ,第3期

机译：Re：年龄相关黄斑变性治疗的比较试验（CATT）研究组，等人：抗血管内皮生长因子治疗新生血管年龄相关性黄斑变性的五年结果：年龄相关黄斑变性治疗的比较试验（2016年眼科; 123：1751-1761）回复
3. MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen [J] . Mantel Irmela, Dirani Ali, Zola Marta, Retina . 2019 ,第5期

机译：黄色萎缩性抗血管内皮生长因子治疗的新生血管年龄相关黄斑病毒变性风险因子评估，其根据观察和计划方案的ranibizumab或aflibercep的个性化治疗需要
4. A targeted drug delivery platform for assisting retinal surgeons for treating Age-related Macular Degeneration (AMD) [C] . M. A. Nasseri, M. Maier, C. P. Lohmann Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2017

机译：靶向药物递送平台，用于辅助视网膜外科医生治疗年龄相关的黄斑变性（AMD）
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients [O] . Se Young Kim, Myung Hun Yoon, Hee Seung Chin 2020

机译：玻璃体腔内注射抗血管内皮生长因子后老年相关性黄斑变性患者神经节细胞内Plexiform层的变化。
7. Retinal Ganglion Cell Layer Change in Patients Treated With Anti–Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration [O] . Beck Marco, Munk Marion R., Ebneter Andreas, 2016

机译：抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的患者视网膜神经节细胞层变化

Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

摘要

著录项

相似文献

相关主题

期刊订阅